about
Sarcoid neuropathy: clinico-pathological study of 4 new cases and review of the literature.Astrocytosis in parkinsonism: considering tripartite striatal synapses in physiopathology?Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration.Age-dependent α-synuclein aggregation in the Microcebus murinus lemur primateProtein aggregation in the aging retina.Postvaccinal inflammatory neuropathy: peripheral nerve biopsy in 3 cases.Insulin resistance and exendin-4 treatment for multiple system atrophy.The nigrostriatal pathway in Creutzfeldt-Jakob disease.Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration.Neuro-muscular biopsy in Churg-Strauss syndrome: 24 cases.Anti-myelin-associated glycoprotein antibodies and endoneurial cryoglobulin deposits responsible for a severe neuropathy.Emergence of mefA and mefE genes in beta-haemolytic streptococci and pneumococci in FranceUltrastructural identification of peripheral myelin proteins by a pre-embedding immunogold labeling methodSchwannian crystalline-like inclusions bodies (Fardeau-Engel bodies) revisited in peripheral neuropathiesHistopathological features of X-linked Charcot-Marie-Tooth disease in 8 patients from 6 families with different connexin32 mutationsHemorrhagic neuropathy associated with vasculitisRegion-Specific Alterations of Matrix Metalloproteinase Activity in Multiple System AtrophyIntra-axonal protein aggregation in the peripheral nervous system
P50
Q33327532-3A30885A-09E2-4532-AF48-BD685DD8E57CQ34238909-011B6415-E3E4-48E7-80C5-DA99B4BDE72BQ36066469-3EA3A064-9836-4630-A528-91665F2BA3BBQ36435001-56677564-C477-4827-9328-B13DA3764384Q39805664-E3DE051E-A172-4F8B-B272-965437F2F234Q40573424-2A86E6AC-73CE-4770-B0E9-A59B98E8499AQ48249047-F76E6071-9B7D-4A32-A4C5-CE9100826A06Q48565156-D8EABA9A-7051-4BAE-BB7A-610FA3C22E32Q50695778-CACB854F-042E-4CF4-A288-21B3B7C54278Q50772237-AF66306C-70B6-4087-A51D-687B5252699FQ54593878-C0A9E7E1-3876-4926-96AD-06C482FC3169Q60312245-224540DC-382A-451E-BD83-502E2CF59FC5Q73222294-C912D3E5-D441-4D11-95B1-E0D9FDE70A3DQ74169701-EFB293A9-83EF-49E6-8C7F-98FAA5A62983Q74169845-D909FCD6-66A5-48FC-9607-DC5D28BA6FFEQ82250242-93501D79-62A8-4719-8DF9-B126A4C4E462Q85888007-A282DBC4-A956-45BB-BDE2-63E589104481Q87228237-FE08B88F-3811-4030-A579-354306AE3B88
P50
description
investigador
@es
onderzoeker
@nl
researcher
@en
name
Marie-Hélène Canron
@ast
Marie-Hélène Canron
@en
Marie-Hélène Canron
@nl
type
label
Marie-Hélène Canron
@ast
Marie-Hélène Canron
@en
Marie-Hélène Canron
@nl
prefLabel
Marie-Hélène Canron
@ast
Marie-Hélène Canron
@en
Marie-Hélène Canron
@nl
P106
P31
P496
0000-0003-1032-7632